Drug Trials Snapshots: EXBLIFEP (cefepime and enmetazobactam)

EXBLIFEP is a combination of cefepime and enmetazobactam that is indicated for the treatment of patients 18 years and older with complicated urinary tract infections (cUTI), including pyelonephritis, caused by designated susceptible microorganisms. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-exblifep